Cleerly Launches With $43 Million Series B To Provide A New Standard Of Care For The Leading Cause Of Death – Heart Disease
NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, launched today with $43 million in Series B funding and unveiled its first-of-its-kind digital care pathway…